Multiple Endocrine Neoplasia Type 2 (MEN2) is a hereditary syndrome characterized by the presence of medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism, resulting from mutations in the RET proto-oncogene. Early diagnosis and genetic testing are critical for effective management and prevention of associated malignancies in affected individuals and their families.